- Home
- ARQ vs ATAI Comparison
ARQ vs ATAI Comparison
Compare ARQ & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQ
- ATAI
- Stock Information
- Founded
- ARQ 1996
- ATAI 2018
- Country
- ARQ United States
- ATAI Germany
- Employees
- ARQ N/A
- ATAI N/A
- Industry
- ARQ
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- ARQ
- ATAI Health Care
- Exchange
- ARQ NYSE
- ATAI Nasdaq
- Market Cap
- ARQ 269.8M
- ATAI 280.2M
- IPO Year
- ARQ N/A
- ATAI 2021
- Fundamental
- Price
- ARQ $5.50
- ATAI $1.99
- Analyst Decision
- ARQ Strong Buy
- ATAI Strong Buy
- Analyst Count
- ARQ 1
- ATAI 4
- Target Price
- ARQ $10.00
- ATAI $9.00
- AVG Volume (30 Days)
- ARQ 201.4K
- ATAI 4.9M
- Earning Date
- ARQ 03-05-2025
- ATAI 03-27-2025
- Dividend Yield
- ARQ N/A
- ATAI N/A
- EPS Growth
- ARQ N/A
- ATAI N/A
- EPS
- ARQ N/A
- ATAI N/A
- Revenue
- ARQ $110,023,000.00
- ATAI $331,000.00
- Revenue This Year
- ARQ $12.76
- ATAI $80.07
- Revenue Next Year
- ARQ $29.04
- ATAI N/A
- P/E Ratio
- ARQ N/A
- ATAI N/A
- Revenue Growth
- ARQ 16.44
- ATAI N/A
- 52 Week Low
- ARQ $3.25
- ATAI $1.03
- 52 Week High
- ARQ $8.26
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- ARQ 30.98
- ATAI 51.96
- Support Level
- ARQ $5.55
- ATAI $1.94
- Resistance Level
- ARQ $6.00
- ATAI $2.16
- Average True Range (ATR)
- ARQ 0.22
- ATAI 0.34
- MACD
- ARQ -0.03
- ATAI -0.03
- Stochastic Oscillator
- ARQ 1.03
- ATAI 48.38
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.